Eddy S. Leman, Ph.D. - Publications

Affiliations: 
2002 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Oncology, Pathology, Molecular Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Leman ES, Magheli A, Cannon GW, Mangold L, Partin AW, Getzenberg RH. Erratum: Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2 (Prostate (2009) 69 (1188-1194)) The Prostate. 72. PMID 22803194 DOI: 10.1002/Pros.22529  0.763
2012 Leman E, Huang W, Contreras-Trujillo H, Volksmer J, Willingham S, Barron A, Gonzalgo M. 1072 INHIBITION OF BLADDER CANCER CELL GROWTH BY TREATMENT WITH SYNTHETICALLY DERIVED ANTI-CANCER PEPTOIDS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1178  0.356
2009 Leman ES, Magheli A, Yong KM, Netto G, Hinz S, Getzenberg RH. Identification of nuclear structural protein alterations associated with seminomas. Journal of Cellular Biochemistry. 108: 1274-9. PMID 19795381 DOI: 10.1002/Jcb.22357  0.561
2009 Leman ES, Getzenberg RH. Biomarkers for prostate cancer. Journal of Cellular Biochemistry. 108: 3-9. PMID 19507229 DOI: 10.1002/Jcb.22227  0.757
2009 Leman ES, Magheli A, Cannon GW, Mangold L, Partin AW, Getzenberg RH. Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2 Prostate. 69: 1188-1194. PMID 19418497 DOI: 10.1002/Pros.20963  0.721
2009 Inoue T, Maeno A, Talbot C, Zeng Y, Yeater DB, Leman ES, Kulkarni P, Ogawa O, Getzenberg RH. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells. The Prostate. 69: 861-73. PMID 19267365 DOI: 10.1002/Pros.20936  0.728
2009 Leman ES, Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH. W1889 Blood-Based Detection of Colon Cancer Utilizing Specific Nuclear Matrix Proteins Gastroenterology. 136: A-748. DOI: 10.1016/S0016-5085(09)63448-X  0.615
2009 Inoue T, Maeno A, Kulkarni P, Zeng Y, Yeater D, Leman E, Ogawa O, Getzenberg R. POD-04.01: Purine-Rich Element Binding Protein Alpha Induces Cell Stress and Differentiation Pathways in Prostate Cancer Cells Urology. 74: S10. DOI: 10.1016/j.urology.2009.07.1177  0.652
2008 Inoue T, Leman ES, Yeater DB, Getzenberg RH. The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer. The Prostate. 68: 1048-56. PMID 18386260 DOI: 10.1002/Pros.20764  0.728
2008 Leman ES, Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer Clinical Cancer Research. 14: 1349-1354. PMID 18316554 DOI: 10.1158/1078-0432.Ccr-07-4110  0.619
2008 Walgenbach-Brunagel G, Burger B, Leman ES, Walgenbach KJ, Tolba R, Heukamp L, Hirner A, Getzenberg RH. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer. Journal of Cellular Biochemistry. 104: 286-94. PMID 18044711 DOI: 10.1002/Jcb.21619  0.625
2008 Leman ES, Getzenberg RH. Nuclear structure as a source of cancer specific biomarkers. Journal of Cellular Biochemistry. 104: 1988-93. PMID 17455233 DOI: 10.1002/Jcb.21363  0.681
2008 Leman ES, Magheli A, Cannon GW, Sokoll LJ, Chan DW, Mangold LA, Partin AW, Getzenberg RH, Getzenberg RH. ANALYSIS OF A SECOND EPCA-2 EPITOPE AS A SERUM TEST FOR PROSTATE CANCER Journal of Urology. 179: 704-704. DOI: 10.1016/S0022-5347(08)62052-2  0.757
2008 Inoue T, Leman ES, Yeater D, Getzenberg RH. PURINE-ELEMENT BINDING PROTEIN (PUR) α AS A NOVEL TREATMENT TARGET FOR HORMONE-REFRACTORY PROSTATE CANCER Journal of Urology. 179: 46-47. DOI: 10.1016/S0022-5347(08)60140-8  0.709
2008 Christodouleas J, Yeater D, Jabbour S, Mangold L, Leman E, Drew R, Humphreys E, Partin A, Getzenberg R, DeWeese T. Modulation of EPCA-2 Levels in Men with Localized Prostate Cancer Treated with Radiation with or without Androgen Suppression Therapy International Journal of Radiation Oncology*Biology*Physics. 72: S316. DOI: 10.1016/J.Ijrobp.2008.06.1091  0.672
2007 Leman ES, Schoen RE, Weissfeld JL, Cannon GW, Sokoll LJ, Chan DW, Getzenberg RH. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Research. 67: 5600-5. PMID 17575123 DOI: 10.1158/0008-5472.Can-07-0649  0.589
2007 Leman ES, Cannon GW, Trock BJ, Sokoll LJ, Chan DW, Mangold L, Partin AW, Getzenberg RH. EPCA-2: a highly specific serum marker for prostate cancer. Urology. 69: 714-20. PMID 17445657 DOI: 10.1016/J.Urology.2007.01.097  0.76
2007 Leman ES, Cannon GW, Track BJ, Sokoll LJ, Chan DW, Mangold LA, Partin AW, Nickel JC, Dimitrakov JD, Getzenberg RH. 1431: Further Analysis of Serum Based EPCA-2 as a Specific Prostate Cancer Associated Biomarker Journal of Urology. 177: 472-472. DOI: 10.1016/S0022-5347(18)31632-X  0.759
2003 Kasai M, Guerrero-Santoro J, Friedman R, Leman ES, Getzenberg RH, DeFranco DB. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Research. 63: 4927-35. PMID 12941817  0.58
2003 Leman ES, Arlotti JA, Dhir R, Getzenberg RH. Vitamin D and androgen regulation of prostatic growth. Journal of Cellular Biochemistry. 90: 138-47. PMID 12938163 DOI: 10.1002/Jcb.10605  0.68
2003 Leman ES, DeMiguel F, Gao AC, Getzenberg RH. Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells. The Journal of Urology. 170: 235-40. PMID 12796696 DOI: 10.1097/01.Ju.0000060117.61770.35  0.664
2003 Leman ES, Getzenberg RH. Effects of 1,25-dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cells. Journal of Cellular Biochemistry. 88: 609-22. PMID 12532336 DOI: 10.1002/Jcb.10371  0.687
2003 Leman ES, Madigan MC, Brünagel G, Takaha N, Coffey DS, Getzenberg RH. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry. 88: 599-608. PMID 12532335 DOI: 10.1002/Jcb.10368  0.746
2002 Leman ES, Getzenberg RH. Nuclear matrix proteins as biomarkers in prostate cancer. Journal of Cellular Biochemistry. 86: 213-23. PMID 12111991 DOI: 10.1002/Jcb.10218  0.751
2002 Leman ES, Arlotti JA, Dhir R, Greenberg N, Getzenberg RH. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry. 86: 203-12. PMID 12111990 DOI: 10.1002/Jcb.10216  0.751
2001 Leman ES, Sisken BF, Zimmer S, Anderson KW. Studies of the interactions between melatonin and 2 Hz, 0.3 mT PEMF on the proliferation and invasion of human breast cancer cells. Bioelectromagnetics. 22: 178-84. PMID 11255213 DOI: 10.1002/Bem.36  0.336
2000 KONETY BR, LEMAN E, VIETMEIER B, ARLOTTI J, DHIR R, GETZENBERG RH. IN VITRO AND IN VIVO EFFECTS OF VITAMIN D (CALCITRIOL) ADMINISTRATION ON THE NORMAL NEONATAL AND PREPUBERTAL PROSTATE Journal of Urology. 164: 1812-1818. DOI: 10.1016/S0022-5347(05)67112-1  0.723
Show low-probability matches.